INTRODUCTION
============

Cardiovascular diseases occur more frequently in patients with metabolic syndrome.[@B1] In particular, in middle-aged men with metabolic syndrome the risk of total mortality due to cardiovascular diseases is 2.6--3.0 times higher than observed in individuals without metabolic syndrome.[@B2] Insulin resistance is important in metabolic syndrome and is associated with many diseases including coronary disease, hypertension, adult-onset diabetes, obesity, and stroke.[@B3][@B4][@B5][@B6]

Dyslipidemia is also a risk factor for cardiovascular diseases. Conventionally, the role of triglycerides (TGs), high-density lipoprotein cholesterol (HDLC), and low-density lipoprotein cholesterol (LDLC) have been emphasized. High TG and low HDLC are independent risk factors of cardiovascular diseases.[@B7][@B8] TGs and HDLC are also components of metabolic syndrome. In practice, many clinicians focus primarily on LDLC in high-risk cardiovascular patients. However, 60% to 70% of cardiovascular events occur despite therapy to lower LDLC levels.[@B9] Also, a prior study reported that high LDLC levels do not increase the risk of mortality in women.[@B10]

Recently, the TG/HDLC ratio was suggested as a compliment to LDLC for predicting the risk of cardiovascular diseases. The TG/HDLC ratio is significantly related to insulin resistance[@B11][@B12][@B13] and also appears to be useful in predicting the development of diabetes,[@B14] coronary heart disease, and cardiovascular mortality.[@B15] Previous studies have demonstrated that the TG/HDLC ratio is a better screening index for insulin resistance than the homeostasis model assessment for insulin resistance.[@B16]

It would be clinically useful to identify insulin-resistant individuals before the appearance of cardiovascular diseases. One method has been to assess the number of criteria for metabolic syndrome present in a patient.[@B17] Several studies have suggested that the TG/HDLC ratio can identify insulin-resistant individuals in a simpler manner.[@B11][@B12][@B13] Also, the TG/HDLC ratio has been shown to be comparable to of the use of metabolic syndrome criteria in identifying insulin resistance in apparently healthy individuals.[@B18][@B19]

Data on the association between the TG/HDLC ratio and metabolic syndrome in the Korean population is limited. If the TG/HDLC ratio could be shown to be closely associated to metabolic syndrome, measurement of the TG/HDLC ratio may be clinically useful because of its simplicity. Determination of the TG/HDLC ratio does not require a measurement of waist circumference, a measurement that varies with sex and ethnicity and is not routinely checked in clinical situations. We aimed to elucidate the relationship between the TG/HDLC ratio and metabolic syndrome in the general Korean population.

METHODS
=======

We evaluated the original data of adults aged ≥20 years who were enrolled in the Korean National Health and Nutrition Examination Survey in 2013 and 2014. Subjects with a history of angina pectoris, myocardial infarction, stroke, or cancer were excluded from the study. The metabolic syndrome definition was based on the harmonized definition emphasizing variations of waist circumference according to racial groups.[@B17] Metabolic syndrome was defined by fulfilling ≥3 components. For central obesity, the definition of the Korean Society for The Study of Obesity was used.[@B20] Because most drugs for the treatment of dyslipidemia (statins) primarily target the lowering of LDLC, the use of medication for dyslipidemia was ignored.

The following were the components used to assess for the presence of metabolic syndrome: (1) waist circumference \>90 cm (men), \>85 cm (women); (2) hypertriglycemia TG ≥150 mg/dL; (3) HDLC \<40 mg/dL (men), \<50 mg/dL (women); (4) hypertension: systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or on antihypertensive medication; and (5) fasting glucose ≥100 mg/dL or on medication for hyperglycemia.

1. Statistical Analysis
-----------------------

The original data from the 2013 and 2014 Korean National Health and Nutrition Examination were merged. Only the data of significant figures needed for analysis were used. Age (categorization), smoking status, drinking status, daytime physical activity, numbers of components of metabolic syndrome, metabolic syndrome status, quartiles for the TG/HDLC ratio, and LDLC, a chi-square test and t-test were conducted. The LDLC level was calculated using Friedewald\'s equation (LDLC=TC-HDLC-TG/5). The relationship between the number of metabolic syndrome components and the TG/HDLC ratio was analyzed by multiple regression, and the odds ratio (OR) of metabolic syndrome according to the TG/HDLC ratio was analyzed by logistic regression. Weighted complex sample analysis was conducted. All analyses were performed using SAS ver. 9.4 (SAS Institute Inc., Cary, NC, USA).

RESULTS
=======

1. General Characteristics of the Study Population
--------------------------------------------------

From the total 32,875,039 selected adults (16,375,805 men \[49.81%\] and 16,499,234 women \[50.19%\]), 4,200,892 men (25.65%) and 2,956,022 women (17.92%) met the criteria of metabolic syndrome. In both men and women, metabolic syndrome was significantly associated with age, drinking, exercise, blood pressure, waist circumference, white blood cell count, fasting glucose, and lipid profile ([Table 1](#T1){ref-type="table"}). In men, the TG/HDLC ratio was 2.73±0.05 in those without metabolic syndrome and 6.80±0.20 in those with metabolic syndrome, a statistically significant difference (P\<0.001). In women, the TG/HDLC ratio was 1.73±0.03 in those without metabolic syndrome and 4.65±0.11 in those with metabolic syndrome, also a statistically significant difference (P\<0.001).

2. The Relationship between the Triglyceride/High-Density Lipoprotein Cholesterol Ratio and the Number of Components of Metabolic Syndrome
------------------------------------------------------------------------------------------------------------------------------------------

The mean value of the TG/HDLC ratio increased as the number of metabolic syndrome components increased: 1.61 with no components; 2.71 with 1 component; 4.20 with 2 components; 6.17 with 3 components; 7.33 with 4 components; and 10.92 with 5 components in men. In women, the mean TG/HDLC ratio was 1.17 with no components; 1.78 with 1 component; 2.92 with 2 components; 3.98 with 3 components; 5.39 with 4 components; and 6.34 with 5 components. The ratio increased significantly with the increase in the number of components present (P\<0.001) ([Table 2](#T2){ref-type="table"}).

3. The Odds Ratios for Metabolic Syndrome according to the Triglyceride/High-Density Lipoprotein Cholesterol Ratio
------------------------------------------------------------------------------------------------------------------

The TG/HDLC ratio was divided by quartile. After adjustment, the OR for metabolic syndrome in the fourth quartile compared with that of the first quartile was 29.65 in men and 20.60 in women (P\<0.001) ([Table 3](#T3){ref-type="table"}).

DISCUSSION
==========

In this study, we aimed to elucidate the relationship between the TG/HDLC ratio and the presence of metabolic syndrome characterized by insulin resistance. The TG/HDLC ratio accordingly increased significantly in both men and women with an increase in the number of metabolic syndrome components present. In a previous study that investigated the relationship between the TG/HDLC ratio and metabolic syndrome in Koreans visiting a health-screening center, the cutoff value of the TG/HDLC ratio in the fourth quartile of was ≥2.93.[@B21] In present study, the fourth quartile was 3.52. The OR for metabolic syndrome was 29.65 in men and 20.60 in women.

Metabolic syndrome is characterized by insulin resistance and is primarily caused by central obesity. A recent meta-analysis showed that the total mortality rate was lower in overweight people as defined by body mass index (BMI).[@B22] In adult males, central obesity with normal weight defined by BMI was twice as high as the total mortality of being overweight or obese by BMI without central obesity.[@B23] Central obesity and insulin resistance are important components of the metabolic syndrome.

The finding that the TG/HDLC ratio is significantly related to metabolic syndrome can be explained based on multiple mechanisms. First, the TG/HDLC ratio predicts insulin resistance.[@B11][@B12][@B13] Insulin resistance promotes the accumulation of fat in the body, resulting in obesity. Insulin resistance also facilitates the progression to pre-diabetes or diabetes, and is associated with hypertension. Moreover, insulin resistance induces endothelial dysfunction of the blood vessels and is associated with oxidant stress and hormone and cytokine secretion from fat cells, resulting in inflammation that promotes the development of atherosclerosis.

Second, the TG/HDLC ratio is known to predict the level of detrimental LDLC subtypes including type B LDLC.[@B24][@B25] There are several sub-types of LDLC, and types A and B have received the greatest attention. Type A LDLC is large in volume and is not considered to be harmful. However, the smaller and denser type B LDLC is easily oxidized and triggers inflammation and atherosclerosis, resulting in arterial stiffness.[@B26][@B27] The TG/HDLC ratio is independently associated with an increase in arterial stiffness in healthy individuals.[@B28]

A strength of this study is that the results are reliable in terms of general applicability to the Korean population. A weakness of this cross-sectional study is the lack of clinical outcomes, we cannot conclude that the TG/HDLC ratio is as powerful in predicting clinical outcomes as is the metabolic syndrome. Further studies are needed to determine which factors, including the TG/HDLC ratio, best predict the morbidity and mortality rate of cardiovascular diseases in patients with the metabolic syndrome. Because lipid profiles vary with nationality, gender, and ethnicity, additional studies are needed to determine the appropriate cutoff points of the TG/HDLC ratio among these different populations.
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###### General characteristics according to the number of metabolic syndrome components
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Values are presented as number (%) or mean±standard error, unless otherwise stated.

BP, blood pressure; TG, triglyceride; HDLC, high-density lipoprotein cholesterol.

^\*^P\<0.05. ^\*\*^P\<0.01. ^\*\*\*^P\<0.001.

###### TG/HDLC ratio according to the number of metabolic components present
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P-values were calculated using simple regression analysis.

TG, triglyceride; HDLC, high-density lipoprotein cholesterol; CL, confidence level.

###### Odds ratios for metabolic syndrome across the TG/HDLC ratio quartiles
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TG, triglyceride; HDLC, high-density lipoprotein cholesterol; CL, confidence level.

^\*^P\<0.05. ^\*\*^P\<0.01. ^\*\*\*^P\<0.001. ^†^Adjusted for age, smoking status, alcohol history, waist circumference, HDLC, low-density lipoprotein cholesterol, blood pressure, fasting glucose, and white blood cell count.
